We recruited patients ( 18 years old ) with unresectable locally advanced or metastatic gastric or oesophagogastric junction adenocarcinoma , an Eastern Cooperative Oncology Group ( ECOG ) performance status of 0 or 1 , who had not received previous systemic therapy , from 43 sites worldwide .